Benedikt Westphalen: First results of CUPISCO presented at ESMO23

Quoting Benedikt Westphalen, Medical Lead Precision Oncology, on X/Twitter:

“First results of CUPISCO presented at ESMO23.

Comprehensive genomic profiling, an MTB, and targeted treatments improve progression-free survival in patients with poor prognosis cancer of unknown primary over platinum CTX.

THIS IS BIG ”

Source: Benedikt Westphalen/Twitter